During phase one of the study, researchers found that students with autism spectrum disorder detected fewer hazards than control participants during simulated drives.
Health Canada is currently reviewing bivalent booster candidates from Moderna and Pfizer-BioNTech, which leaves some Canadians debating whether to wait for the revamped shots or go for a booster now.